1. Home
  2. VKTX vs KBH Comparison

VKTX vs KBH Comparison

Compare VKTX & KBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • KBH
  • Stock Information
  • Founded
  • VKTX 2012
  • KBH 1957
  • Country
  • VKTX United States
  • KBH United States
  • Employees
  • VKTX N/A
  • KBH N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • KBH Homebuilding
  • Sector
  • VKTX Health Care
  • KBH Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • KBH Nasdaq
  • Market Cap
  • VKTX 3.5B
  • KBH 3.8B
  • IPO Year
  • VKTX 2015
  • KBH 1987
  • Fundamental
  • Price
  • VKTX $34.42
  • KBH $56.82
  • Analyst Decision
  • VKTX Strong Buy
  • KBH Buy
  • Analyst Count
  • VKTX 13
  • KBH 12
  • Target Price
  • VKTX $86.92
  • KBH $67.04
  • AVG Volume (30 Days)
  • VKTX 4.1M
  • KBH 1.7M
  • Earning Date
  • VKTX 07-23-2025
  • KBH 09-23-2025
  • Dividend Yield
  • VKTX N/A
  • KBH 1.76%
  • EPS Growth
  • VKTX N/A
  • KBH 0.49
  • EPS
  • VKTX N/A
  • KBH 7.59
  • Revenue
  • VKTX N/A
  • KBH $6,673,869,000.00
  • Revenue This Year
  • VKTX N/A
  • KBH N/A
  • Revenue Next Year
  • VKTX N/A
  • KBH N/A
  • P/E Ratio
  • VKTX N/A
  • KBH $7.49
  • Revenue Growth
  • VKTX N/A
  • KBH 3.65
  • 52 Week Low
  • VKTX $18.92
  • KBH $48.90
  • 52 Week High
  • VKTX $81.73
  • KBH $89.70
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 73.08
  • KBH 55.99
  • Support Level
  • VKTX $31.22
  • KBH $53.42
  • Resistance Level
  • VKTX $33.61
  • KBH $59.62
  • Average True Range (ATR)
  • VKTX 1.77
  • KBH 1.81
  • MACD
  • VKTX 0.32
  • KBH 0.24
  • Stochastic Oscillator
  • VKTX 89.49
  • KBH 61.27

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

Share on Social Networks: